Last reviewed · How we verify

NCT06940037: BRIO

The Impact of Biological Mechanisms of Aging on Response Variability to Resistance Training in Older Adults

Recruiting now NA Last updated 16 September 2025
What this trial tests

NA trial testing Progressive Resistance Training in Aging in 300 participants. Currently enrolling.

Timeline
11 August 2025
Primary endpoint
31 August 2029
31 August 2030

Quick facts

Lead sponsorMayo Clinic
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposebasic science
Enrollment300
Start date11 August 2025
Primary completion31 August 2029
Estimated completion31 August 2030
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Mayo Clinic

Who can join

65 and older, any sex, with Aging or Mobility Disability. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To critically examine biological, clinical, and behavioral modulators of progressive resistance training-associated exercise response heterogeneity in physical function and whole-body metabolism in older adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Progressive Resistance Training

Trials testing the same drug.

Other recruiting trials for Aging

Currently open trials in the same condition.

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06940037.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing